Regenxbio Inc recently announced that the company expects to hold a Type A meeting with the U.S. Food and Drug Administration (FDA) in July this year.

老虎证券2026/06/22 11:51

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This meeting aims to hold key discussions regarding the relevant Biologics License Application (BLA). After the meeting, the company plans to act swiftly and resubmit the BLA application within the third quarter of 2026. This timeline highlights the company’s determination and efficiency in advancing its research and development pipeline.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Regenxbio Inc recently announced that the company expects to hold a Type A meeting with the U.S. Food and Drug Administration (FDA) in July this year.

You may also like

Crypto prices